A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia

NCT06387420 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

ACUTE MYELOID LEUKEMIA; AML

Interventions

DRUG: AK117
DRUG: Azacitidine
DRUG: Venetoclax
OTHER: Placebo

Sponsor

Akeso